Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 7/20 | 0.54 |
| ▸ | RAB9A | P51151 | 6/20 | 0.54 |
| ▸ | NPC1 | O15118 | 5/20 | 0.54 |
| ▸ | HTT | P42858 | 5/20 | 0.54 |
| ▸ | POLB | P06746 | 4/20 | 0.54 |
| ▸ | MAPK1 | P28482 | 4/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.54 |
| ▸ | XBP1 | P17861 | 3/20 | 0.54 |
| ▸ | MDM2 | Q00987 | 3/20 | 0.54 |
| ▸ | AGTR1 | P30556 | 3/20 | 0.54 |
| ▸ | GPR55 | Q9Y2T6 | 3/20 | 0.54 |
| ▸ | TERT | O14746 | 1/20 | 0.54 |
| ▸ | GLA | P06280 | 1/20 | 0.54 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.54 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.53 |
| ▸ | RECQL | P46063 | 2/20 | 0.47 |
| ▸ | PKM | P14618 | 2/20 | 0.47 |
| ▸ | PAX8 | Q06710 | 2/20 | 0.47 |
| ▸ | THRB | P10828 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ambrosin SCHEMBL3463663 | 1.00 | MAPT (0.54) | MAPTRAB9ANPC1HTTPOLB | |
| Damsin SCHEMBL18642934 | 0.73 | PTGS2 (0.55) | MAPTRAB9ANPC1HTTMAPK1 | |
| Damsin SCHEMBL18642932 | 0.73 | PTGS2 (0.55) | MAPTRAB9ANPC1HTTMAPK1 | |
| Helenalin SCHEMBL11030579 | 0.70 | MAPT (1.00) | MAPTRAB9ANPC1HTTPOLB | |
| Helenalin SCHEMBL10132557 | 0.70 | MAPT (1.00) | MAPTRAB9ANPC1HTTPOLB | |
| Helenalin SCHEMBL161594 | 0.70 | MAPT (1.00) | MAPTRAB9ANPC1HTTPOLB | |
| Helenalin SCHEMBL161593 | 0.70 | MAPT (1.00) | MAPTRAB9ANPC1HTTPOLB | |
| Helenalin SCHEMBL31237389 | 0.70 | MAPT (1.00) | MAPTRAB9ANPC1HTTPOLB | |
| Helenalin SCHEMBL10099625 | 0.70 | MAPT (1.00) | MAPTRAB9ANPC1HTTPOLB | |
| Mexicanin I SCHEMBL17238871 | 0.70 | MAPT (1.00) | MAPTRAB9ANPC1HTTPOLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 117 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3349584-B1 | MEDICINAL AMBROSIA PLANT EXTRACTS | EL SAWY MOHAMED FAKHR EL DIN (EG) | 2025-07-16 | — | — | EP | claimed |
| US-11911428-B2 | Medicinal ambrosia maritima extracts | HELMY SHERINE HASSAN ABBAS (EG) | 2024-02-27 | — | — | US | claimed |
| US-20220362321-A1 | MEDICINAL AMBROSIA MARITIMA EXTRACTS | HELMY SHERINE HASSAN ABBAS (EG) | 2022-11-17 | — | — | US | claimed |
| US-10653739-B2 | Medicinal ambrosia maritima extracts | EL SAWY MOHAMED FAKHR EL DIN (EG) | 2020-05-19 | — | — | US | claimed |
| CN-108348561-A | Extract of ragweed plant | 穆罕默德·法赫尔·埃尔-丁·埃尔-萨维 | 2018-07-31 | — | — | CN | claimed |
| EP-3349584-A1 | MEDICINAL AMBROSIA PLANT EXTRACTS | El-Sawy, Mohamed Fakhr El-Din (EG) | 2018-07-25 | — | — | EP | claimed |
| WO-2017044860-A1 | MEDICINAL AMBROSIA PLANT EXTRACTS | EL-SAWY MOHAMED FAKHR EL-DIN (EG) | 2017-03-16 | — | — | WO | claimed |
| US-20170071994-A1 | MEDICINAL AMBROSIA MARITIMA EXTRACTS | EL-SAWY MOHAMED FAKHR EL-DIN (EG) | 2017-03-16 | — | — | US | claimed |
| EP-3349584-B1 | MEDICINAL AMBROSIA PLANT EXTRACTS | EL SAWY MOHAMED FAKHR EL DIN (EG) | 2025-07-16 | — | — | EP | disclosed |
| US-11911428-B2 | Medicinal ambrosia maritima extracts | HELMY SHERINE HASSAN ABBAS (EG) | 2024-02-27 | — | — | US | disclosed |
| US-20220362321-A1 | MEDICINAL AMBROSIA MARITIMA EXTRACTS | HELMY SHERINE HASSAN ABBAS (EG) | 2022-11-17 | — | — | US | disclosed |
| US-20210317099-A1 | SAFER, POTENT, AND FAST ACTING ANTIMICROBIAL AGENTS | PURDUE RESEARCH FOUNDATION (US) | 2021-10-14 | — | — | US | disclosed |
| CN-111565716-A | Methods of using dipivefrin | 因斯格尼斯疗法有限公司 | 2020-08-21 | — | — | CN | disclosed |
| US-20200222485-A1 | MEDICINAL AMBROSIA PLANT EXTRACTS | EL SAWY MOHAMED FAKHR EL DIN (EG) | 2020-07-16 | — | — | US | disclosed |
| EP-0980262-A1 | SOLID PHARMACEUTICAL FORMULATIONS CONTAINING A PHYSICAL MIXTURE OF SULFOALKYL ETHER CYCLODEXTRIN AND A THERAPEUTIC AGENT | Cydex Inc. (US) | 2000-02-23 | — | — | EP | disclosed |
| US-5981577-A | ANTITUMOR ACTIVITY | DEVELOPMENT CENTER FOR BIOTECHNOLOGY (TW) | 1999-11-09 | — | — | US | disclosed |
| WO-1999035150-A1 | SYNTHESIS OF COMBRETASTATIN A-4 PRODRUGS AND TRANS-ISOMERS THEREO F | ARIZONA BOARD OF REGENTS, A BODY CORPORATE, ACTING ON BEHALF OF ARIZONA STATE UNIVERSITY (US) | 1999-07-15 | — | — | WO | disclosed |
| US-5905089-A | USEFUL IN SUPPRESSING EARLY PROINFLAMMATORY CYTOKINES AND IN AMELIORATING SEPTIC SHOCK AND OTHER SEVERE INFLAMMATORY DISORDERS | BOARD OF SUPERVISORS OF LOUISIANA STATE UNIVERSITY AND AGRICULTURAL AND MECHANICAL COLLEGE (US) | 1999-05-18 | — | — | US | disclosed |
| US-5874418-A | SUSTAINED RELEASE | CYDEX, INC. (US) | 1999-02-23 | — | — | US | disclosed |
| WO-1998050077-A1 | SOLID PHARMACEUTICAL FORMULATIONS CONTAINING A PHYSICAL MIXTURE OF SULFOALKYL ETHER CYCLODEXTRIN AND A THERAPEUTIC AGENT | CYDEX INC. (US) | 1998-11-12 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210317099-A1 | SAFER, POTENT, AND FAST ACTING ANTIMICROBIAL AGENTS | MIF, LTA, MGAM | MAPT 3922/4885RAB9A 3395/4885NPC1 4363/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.